T. Rowe Price Associates’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
T. Rowe Price Associates's OGN Position: Q1 2026 in Review
T. Rowe Price Associates increased its Organon & Co (OGN) stake by 20% in Q1 2026, buying an estimated $256K and bringing the position to 201,132 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2062.
T. Rowe Price Associates first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $23.1M in Q2 2021. 604 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- T. Rowe Price Associates held 201,132 shares of Organon & Co worth $1.21M as of Q1 2026.
- T. Rowe Price Associates bought 34,011 Organon & Co shares in Q1 2026, an estimated $256K.
- Organon & Co made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2062 holding.
- T. Rowe Price Associates first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
- T. Rowe Price Associates's Organon & Co position peaked at $23.1M in Q2 2021.
- 604 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.